Annual Report 2025

A comprehensive review of fiscal performance, strategic initiatives, and global impact across 400 subsidiaries.

Fiscal Period Jan 1 – Dec 31, 2025
Auditor KPMG Global Assurance
Filing Reference AZC-2025-10K
Currency USD (in billions)

Financial Highlights

Record-breaking fiscal year driven by strategic acquisitions, R&D commercialization, and cross-divisional synergies.

Total Revenue +14.2%
$94.3B
vs $82.6B in FY 2024
Net Income +18.7%
$18.1B
Margin: 19.2%
EPS (Diluted) +16.4%
$42.85
Consistent double-digit growth
R&D Investment +22.1%
$12.4B
13.1% of total revenue

FY 2025 marked a transformative chapter for Aevum Zenth. By aligning our 400 subsidiaries under a unified innovation framework, we accelerated commercialization across energy transition, quantum computing, and advanced biotech. Our disciplined capital allocation and focus on sustainable growth delivered record profitability while expanding our footprint in 8 new markets. We remain steadfast in our commitment to ethical governance, technological sovereignty, and long-term shareholder value.

EC

Elena Corves

Chief Executive Officer & Chair of the Board

Performance Breakdown

Revenue distribution by sector and year-over-year operational metrics.

Revenue by Division ($B)

Energy
$21.4
Technology
$23.1
Aerospace
$16.2
Healthcare
$17.8
Financial
$15.8

5-Year Revenue Trajectory

2021
$58.2B
2022
$66.5B
2023
$74.1B
2024
$82.6B
2025
$94.3B
Metric 2021 2022 2023 2024 2025 CAGR
Total Revenue 58.2 66.5 74.1 82.6 94.3 +11.8%
Gross Profit 28.4 32.1 36.8 41.5 47.2 +10.5%
Operating Income 12.6 14.8 16.3 15.2 22.4 +13.2%
Net Income 9.1 10.5 11.8 15.2 18.1 +18.1%
Free Cash Flow 14.2 16.1 17.5 21.3 26.8 +15.9%

Divisional Performance

Operational highlights and profitability metrics across key business units.

Aevum Energy & Power +16.3%
Revenue: $21.4B
Gross Margin 34.2%
CapEx Deployed $6.8B
Zenth Digital Systems +21.1%
Revenue: $23.1B
Gross Margin 48.5%
Active Enterprise Clients 14,200+
Aevum Aerospace +12.8%
Revenue: $16.2B
Defense Contracts $9.4B
Orbital Payloads 142
Zenth Health Sciences +14.5%
Revenue: $17.8B
R&D Pipeline 68 candidates
Phase III Trials 12
Aevum Capital Group +9.4%
Revenue: $15.8B
AUM $412B
ROE 14.6%
Other Divisions +8.2%
Revenue: $0.0B (Consolidated)
Sectors 37 additional
Contribution ~$0.0B

ESG & Sustainability

Progress toward our 2030 sustainability targets and governance standards.

⚡
Carbon Neutrality
Scope 1 & 2 emissions reduction targets across global operations.
78% of 2030 goal achieved
🤝
Social Impact
Workforce diversity, community investment, and supply chain labor standards.
84% workforce gender parity
⚖️
Governance
Board independence, executive compensation alignment, and regulatory compliance.
92% independent directors

Reports & Filings

Access complete audited statements, interactive data, and regulatory submissions.

📄
Full 2025 Annual Report
PDF · 24.8 MB · Audited
📊
Interactive Data Hub
Web App · Live Metrics · API Access
📑
SEC Form 10-K Filing
XBRL · Regulatory · Filing #0001234567
📈
Investor Presentation
PPTX · 18.2 MB · Q4 Earnings Deck